Sarepta Stock Soars: Scotiabank's Upgrade Sparks 10% Gain!

viernes, 6 de junio de 2025, 3:12 pm ET1 min de lectura
SRPT--
Sarepta Therapeutics, Inc. rose 10.32% intraday, with the company receiving an upgrade from Scotiabank, which recommended the stock as a buy. This positive analyst recommendation aligns with the stock's upward movement.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios